S&P 500 Healthcare Sector SPDR (XLV)

Despite Elevance Health's outperformance relative to the broader market over the past 52 weeks, Wall Street analysts remain cautiously optimistic about the stock's prospects.

Revvity has outperformed the broader market over the past year, and analysts are moderately optimistic about the stock’s prospects.

Cooper Companies has underperformed the broader market over the past year, and analysts remain somewhat optimistic about the stock’s prospects.

Despite already outperforming the broader market over the past year, IQVIA continues to enjoy strong backing from Wall Street, with analysts remaining highly optimistic about the stock’s future prospects....

Despite trailing the broader market over the past year, HCA Healthcare continues to command a moderately optimistic outlook from Wall Street analysts, who see room for further upside in the stock.

Despite Agilent Technologies’ strong performance relative to the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Vertex Pharmaceuticals has raced ahead of the market, while analysts continue to give the stock a decidedly optimistic outlook.

Veeva Systems has underperformed the broader market amid softer demand and competition, while analysts remain moderately optimistic about its future prospects.

While Incyte has outperformed the broader market over the past year, Wall Street analysts remain cautiously optimistic about the stock’s prospects.

Thermo Fisher Scientific has underperformed the broader market over the past year, yet analysts remain highly bullish about the stock’s prospects.